BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 32320527)

  • 1. Identification of circulating tumor cells using 4-color fluorescence in situ hybridization: Validation of a noninvasive aid for ruling out lung cancer in patients with low-dose computed tomography-detected lung nodules.
    Katz RL; Zaidi TM; Pujara D; Shanbhag ND; Truong D; Patil S; Mehran RJ; El-Zein RA; Shete SS; Kuban JD
    Cancer Cytopathol; 2020 Aug; 128(8):553-562. PubMed ID: 32320527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
    Li Z; Cai J; Zhao Y; Cai J; Zhao X
    J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules.
    Paez R; Kammer MN; Tanner NT; Shojaee S; Heideman BE; Peikert T; Balbach ML; Iams WT; Ning B; Lenburg ME; Mallow C; Yarmus L; Fong KM; Deppen S; Grogan EL; Maldonado F
    Chest; 2023 Oct; 164(4):1028-1041. PubMed ID: 37244587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Three-Dimensional DNA Fluorescent In Situ Hybridization (3D DNA FISH) for the Detection of Anaplastic Lymphoma Kinase (ALK) in Non-Small Cell Lung Cancer (NSCLC) Circulating Tumor Cells.
    Kulasinghe A; Lim Y; Kapeleris J; Warkiani M; O'Byrne K; Punyadeera C
    Cells; 2020 Jun; 9(6):. PubMed ID: 32549278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy.
    Okabe T; Togo S; Fujimoto Y; Watanabe J; Sumiyoshi I; Orimo A; Takahashi K
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming Obstacles in Pathological Diagnosis of Pulmonary Nodules through Circulating Tumor Cell Enrichment.
    Yin W; Zhu J; Ma B; Jiang G; Zhu Y; He W; Yang Y; Zhang Z
    Small; 2020 Jun; 16(25):e2001695. PubMed ID: 32452626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
    Liu WR; Zhang B; Chen C; Li Y; Ye X; Tang DJ; Zhang JC; Ma J; Zhou YL; Fan XJ; Yue DS; Li CG; Zhang H; Ma YC; Huo YS; Zhang ZF; He SY; Wang CL
    Thorac Cancer; 2020 Nov; 11(11):3234-3242. PubMed ID: 32989915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.
    Feng M; Ye X; Chen B; Zhang J; Lin M; Zhou H; Huang M; Chen Y; Zhu Y; Xiao B; Huang C; Katz RL; Bai C
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2397-2405. PubMed ID: 33547948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer clustering by identification of similarities and discrepancies of DNA copy numbers using maximal information coefficient.
    N Kachouie N; Deebani W; Shutaywi M; Christiani DC
    PLoS One; 2024; 19(5):e0301131. PubMed ID: 38739669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection and identification of circulating tumor cells in parathyroid tumors and correlation analysis with clinicopathological features.
    Wang J; Jiang X; Wang Q; Zhao T; Shen H; Liu X; Feng D; Shen R; Wang Y; Yang W; Wei B
    Endocrine; 2024 May; ():. PubMed ID: 38730070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Early Diagnosis of Lung Cancer: Critical Gaps in the Discovery of Biomarkers.
    Gasparri R; Sabalic A; Spaggiari L
    J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules.
    Tahvilian S; Kuban JD; Yankelevitz DF; Leventon D; Henschke CI; Zhu J; Baden L; Yip R; Hirsch FR; Reed R; Brown A; Muldoon A; Trejo M; Katchman BA; Donovan MJ; Pagano PC
    BMC Pulm Med; 2023 Jun; 23(1):193. PubMed ID: 37277788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Lightweight and Robust Framework for Circulating Genetically Abnormal Cells (CACs) Identification Using 4-Color Fluorescence In Situ Hybridization (FISH) Image and Deep Refined Learning.
    Xu X; Li C; Lan X; Fan X; Lv X; Ye X; Wu T
    J Digit Imaging; 2023 Aug; 36(4):1687-1700. PubMed ID: 37231288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of circulating abnormal cells in early lung cancer.
    Meng H; Yao W; Nan MM; Zhou FG; Song WY; Li YZ; Yin YH; Ding Y
    Am J Cancer Res; 2023; 13(4):1594-1601. PubMed ID: 37168347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis.
    Guo S; Chen J; Hu P; Li C; Wang X; Chen N; Sun J; Wang Y; Wang J; Gu W; Wu S
    Technol Cancer Res Treat; 2023; 22():15330338231166754. PubMed ID: 37093867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multidimensional model incorporating radiomics score and liquid biopsy for the prediction of malignant and benign pulmonary nodules.
    Xu L; Zhou JY; Wang LL; Yang RN; Li TX; Zhu XL
    Transl Cancer Res; 2022 Nov; 11(11):4009-4018. PubMed ID: 36523317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic role of liquid biopsy in non-small cell lung cancer: evaluation of circulating biomarkers.
    Vicidomini G; Cascone R; Carlucci A; Fiorelli A; Di Domenico M; Santini M
    Explor Target Antitumor Ther; 2020; 1(5):343-354. PubMed ID: 36046486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An efficient fluorescence in situ hybridization (FISH)-based circulating genetically abnormal cells (CACs) identification method based on Multi-scale MobileNet-YOLO-V4.
    Xu C; Zhang Y; Fan X; Lan X; Ye X; Wu T
    Quant Imaging Med Surg; 2022 May; 12(5):2961-2976. PubMed ID: 35502367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor-Macrophage Fusion Cells and Circulating Tumor Cells Complement Non-Small-Cell Lung Cancer Screening in Patients With Suspicious Lung-RADS 4 Nodules.
    Manjunath Y; Suvilesh KN; Mitchem JB; Avella Patino DM; Kimchi ET; Staveley-O'Carroll KF; Pantel K; Yi H; Li G; Harris PK; Chaudhuri AA; Kaifi JT
    JCO Precis Oncol; 2022 Mar; 6():e2100378. PubMed ID: 35417204
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.